Delayed-type allergy to articaine with cross-reactivity to other local anesthetics from the amide group

2018 ◽  
Vol 6 (1) ◽  
pp. 305-306 ◽  
Author(s):  
Tiziana Maria Angela De Pasquale ◽  
Alessandro Buonomo ◽  
Stefano Pucci
1975 ◽  
Vol 78 (1) ◽  
pp. 222-231 ◽  
Author(s):  
A. Arimura ◽  
H. Sato ◽  
D. H. Coy ◽  
R. B. Worobec ◽  
A. V. Schally ◽  
...  

ABSTRACT Antigenic determinants of LH-releasing hormone (LH-RH) were investigated by testing the cross-reaction of LH-RH analogues and fragments in LH-RH radioimmunoassay (RIA) systems using 3 different antisera against the LH-RH decapeptide. Rabbit antiserum No. 419 was generated against LH-RH adsorbed on polyvinylpyrrolidone (PVP). Antisera Nos. 710 and 742 were produced by immunizing rabbits with LH-RH conjugated either with bovine serum albumin through its C-terminus, or with human serum albumin through the N-terminus, respectively. For antiserum No. 419, the N-terminal (pyro)-glutamic acid and/or histidine in positions 1 and 2 of LH-RH, respectively, were found to enhance the antigen-antibody interaction, but were not indispensable for it. Similarly, the C-terminal amide and glycine-NH2 did not play a major role in these interactions. The LH-RH heptapeptide fragment, corresponding to amino acid sequence from positions 3 to 9, showed a cross-reactivity in this RIA system with LH-RH, although greater amounts than those of cold LH-RH were required for a comparable inhibition of binding of labelled LH-RH. For antiserum No. 710, the LH-RH hexapeptide fragment corresponding to positions 2 to 7 showed considerable cross-reac tivity. Histidine in position 2 played an important role but neither the amide group nor the glycine amide group at the C-terminus were essential. For antiserum No. 742, the C-terminal tetrapeptide-amide fragment of LH-RH showed considerable cross-reactivity in the LH-RH, the amide moiety itself being of crucial importance. These antisera may be useful in investigating peptides related to LH-RH in biological materials.


Allergy ◽  
2003 ◽  
Vol 58 (8) ◽  
pp. 827-828 ◽  
Author(s):  
M. Morais-Almeida ◽  
A. Gaspar ◽  
S. Marinho ◽  
J. Rosado-Pinto

2016 ◽  
Vol 4 (4) ◽  
pp. 771-772 ◽  
Author(s):  
Javier Domínguez-Ortega ◽  
Elsa Phillips-Angles ◽  
Miguel González-Muñoz ◽  
Rocío Heredia ◽  
Ana Fiandor ◽  
...  

2021 ◽  
Vol Volume 14 ◽  
pp. 47-58
Author(s):  
Ilkay Koca Kalkan ◽  
Gozde Koycu Buhari ◽  
Hale Ates ◽  
Buket Basa Akdogan ◽  
Ozlem Erdem Ozdedeoglu ◽  
...  

2016 ◽  
Vol 28 (10) ◽  
pp. 2575-2581 ◽  
Author(s):  
Serhij Plotycya ◽  
Liliya Dubenska ◽  
Mykola Blazheyevskiy ◽  
Solomiya Pysarevska ◽  
Olha Sarahman

1979 ◽  
Author(s):  
Daniel Walz ◽  
Thomas Brown

Human prothrombin activation is unique in that, in addition to the release of fragment 1.2 (FI.2) from the NH-terminus of prothrombin by factor Xa during the generation of thrombin, an additional 13 residue polypeptide, fragment 3 (F3), is autocatalytically removed from the amino-terminus of the thrombin A chain. We have developed a rapid radioimmunoassay for human F3 which incorporates short incubation times and the use of a preprecipitated second antibody; the assay can be performed in three hours. Specificity studies in buffer systems show prothrombin and prethrombin 1 cross-reacting at a level of 0.001; purified thrombin does not cross-react. In the presence of 5% BSA, prothrombin displays considerably less cross-reactivity. No immunoreactive material to F3 antibodies could be detected in 400 μL of plasma. Serum, obtained from whole blood clotting, contained measurable quantities of F3 (40-100 ng/mL). This amount in serum represents only 5-10% of the theoretical amount available should all of the fragment be hydrolytically cleaved during the conversion of prothrombin to thrombin. This assay procedure is currently being utilized to monitor the activation of purified human prothrombin in the absence and presence of selected plasma inhibitors. (Supported in part by NIH 05384-17 and the Michigan Heart Association).


Sign in / Sign up

Export Citation Format

Share Document